Close
Back to RLMD Stock Lookup

Relmada Therapeutics (RLMD) – Hot Corp. News

Dec 7, 2022 04:07 PM Relmada Therapeutics (RLMD) Phase 3 RELIANCE I Trial for REL-1017 as an Adjunctive Treatment for Major Depressive Disorder Did Not Achieve Primary Endpoint
Oct 13, 2022 07:04 AM Relmada Therapeutics (RLMD) Phase 3 RELIANCE III Trial for REL-1017 Did Not Achieve its Primary Endpoint
Oct 15, 2019 08:06 AM

Back to RLMD Stock Lookup